Charles S. Ryan - 18 Jun 2025 Form 4 Insider Report for Quince Therapeutics, Inc. (QNCX)

Role
President
Signature
/s/ Charles S. Ryan
Issuer symbol
QNCX
Transactions as of
18 Jun 2025
Net transactions value
+$10,001
Form type
4
Filing time
23 Jun 2025, 08:46:04 UTC
Previous filing
11 Feb 2025
Next filing
23 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ryan Charles S. President C/O QUINCE THERAPEUTICS, INC., 611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO /s/ Charles S. Ryan 20 Jun 2025 0001624830

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNCX Common Shares Award $9,058 +7,548 +6.2% $1.20 130,009 18 Jun 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNCX Warrants Award $944 +7,548 $0.1250 7,548 18 Jun 2025 Common Shares 7,548 $1.20 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.